News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices     4/17/2017
Novogen (NVGN) Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs     4/6/2017
Bristol-Myers Squibb (BMY)'s Next Big Bet After Opdivo Failure—IDOs     4/4/2017
Before We Act Impulsively on Drug Prices We Should Make Precision Policies     4/4/2017
Novartis AG (NVS) Looks Over Its Shoulder as Kite Pharma (KITE) Hits Its BLA Filing Deadline     4/3/2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos     3/28/2017
Why This Biotech Says It's Close to Curing the Type of Cancer That Killed Steve Jobs     3/20/2017
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion     3/20/2017
Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data     3/6/2017
6 Biotechs Facing Key FDA Decisions in March     3/2/2017
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial     2/22/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III     2/8/2017
No Looking Back: Cellectis (CLLS) Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial     2/7/2017
AstraZeneca PLC (AZN) Quietly Kills Some Programs     2/6/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering     2/3/2017

News from Around the Web
Google (GOOG) AI Just Beat Human Pathologists At Detecting Cancer     4/5/2017
AbbVie (ABBV)'s New Approach To Fighting Cancer At Their Roots     3/29/2017
Graphene Quantum Dots Expand Role In Cancer Treatment And Bio-Imaging, Dotz Nano Reveals     3/29/2017
First Ever Blood Tests To Diagnose Cancer 'Could Be Ready In One Year', UCLA Reveals     3/27/2017
Urine-Based Biomarkers For Early Cancer Screening Test, Ulsan National Institute of Science and Technology Study     3/8/2017
Ultrafast Detection Of A Cancer Biomarker Enabled By Innovative Nanobiodevice, Nagoya University Reveals     3/8/2017
3D-Printed Metamaterials Can Bend Sound Waves To Improve Medical Diagnostics And Cancer Treatment, Sussex University Reveals     3/1/2017
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)     2/24/2017
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Could A Little Bit Of Fasting Bring A Lot Of Health Benefits? University of Southern California Study     2/17/2017
GW Pharma (GWPH) Is Set To Benefit As Cannabis Takes On Cancer     2/10/2017
Man Who Took Magic Mushrooms Said It Helped Him See A Basic Truth About Relationships     2/6/2017
Aspen Pharmacare's Old Cancer Drug Gets 1,227% Price Hike In Frugal U.K.     1/30/2017
Breath Test Could Help Detect Stomach And Esophageal Cancers, Imperial College London Study     1/30/2017
Scientists Highlight the Hopes and Fears of Cellectis (ALCLS)' CAR-T     1/26/2017

Press Releases
Pfizer (PFE)’s Next-Generation ALK/ROS1 Inhibitor, Lorlatinib, Granted Breakthrough Therapy Designation From FDA For ALK-Positive Metastatic Non-Small Cell Lung Cancer     4/27/2017
Cellectar Biosciences  (CLRB)’s Radiotherapeutic Pdcs Demonstrate An Increased Survival Benefit Using Multiple Doses In Preclinical Studies     4/27/2017
True Health Diagnostics Launches Hereditary Cancer Screening Tool For Primary Care Physicians     4/27/2017
ASLAN Initiates Global Pivotal Study For Varlitinib In Biliary Tract Cancer     4/25/2017
Enamine Ltd. To Collaborate With EMBL For Cancer Drug Discovery Research     4/25/2017
Cellectar Biosciences  (CLRB) Receives Additional U.S. Patents For PDC Optical Agents In The Detection Of Multiple Cancers     4/25/2017
Inovio Pharma (INO) Initiates Phase II Efficacy Trial With VGX-3100 For HPV-Related Vulvar Pre-Cancers     4/24/2017
Sandoz Proposed Biosimilars Rituximab And Etanercept Recommended For Approval In Europe*     4/24/2017
Cancer Genetics (CGIX) Launches A Unique, Industry-Leading Panel That Provides Comprehensive & Precise Information For Immuno-Oncology Therapy Assessment & Patient Monitoring     4/24/2017
Jounce (JNCE) Initiates Phase II Portion Of ICONIC Study Of JTX-2011 In Patients With Advanced Solid Tumors     4/21/2017
Experimental Biology and Medicine Release: Targeting Cancer Cells With An Implantable Drug Delivery System     4/21/2017
Atara Biotherapeutics (ATRA) Announces Collaboration With Merck & Co. (MRK) to Evaluate KEYTRUDA® (Pembrolizumab) In Combination With ATA129 In Nasopharyngeal Carcinoma (NPC)     4/21/2017
Incyte (INCY)'s Immuno-Oncology And Targeted Therapy Clinical Portfolio To Be Featured In More Than 15 Abstracts At The 2017 ASCO Annual Meeting     4/21/2017
ARMO BioSciences Announces Clinical Data Presentation For Immunotherapy AM0010 At The 12th European International Kidney Cancer Symposium     4/21/2017
RedHill Biopharma (RDHL) Announces Peer-Reviewed Publication Of The Positive YELIVA Phase I Study Results In Advanced Solid Tumors     4/20/2017

//-->